Polymorphisms of the androgen receptor gene and the estrogen receptor β gene are associated with androgen levels in women

被引:182
作者
Westberg, L
Baghaei, F
Rosmond, R
Hellstrand, M
Landén, M
Jansson, M
Holm, G
Björntorp, P
Erikson, E
机构
[1] Univ Gothenburg, Dept Pharmacol, SE-40530 Gothenburg, Sweden
[2] Univ Gothenburg, Inst Clin Neurosci, Sect Psychiat, SE-40530 Gothenburg, Sweden
[3] Univ Gothenburg, Inst Heart & Lung Dis, SE-40530 Gothenburg, Sweden
关键词
D O I
10.1210/jc.86.6.2562
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To elucidate the possible role of genetic variation in androgen receptor (AR), estrogen receptor alpha (ER alpha), and ER beta on serum androgen levels in premenopausal women, the CAG repeat polymorphism of the AR gene, the TA repeat polymorphism of the ER alpha gene, and the CA repeat polymorphism of the ER beta gene were studied in a population-based Cohort of 270 women. Total testosterone, free testosterone, dehydroepiandrosterone sulfate, androstenedione, 17-hydroxyprogesterone, 3 alpha -androstanediol glucuronide, 17 beta -estradiol, LH, FSH, and sex steroid hormone-binding globulin (SHBG)were measured in serum samples obtained in the follicular phase of the menstrual cycle. Women with relatively few CAG repeats in the AR gene, resulting in higher transcriptional activity of the receptor, displayed higher levels of serum androgens, but lower levels of LII, than women with longer CAG repeat sequences. The CA repeat of the ER beta gene also was associated with androgen and SHBG levels; women with relatively short repeat regions hence displayed higher hormone levels and lower SHBG; levels than those with many CA repeats. In contrast, the TA repeat of the ER alpha gene was not associated with the levels of any of the hormones measured. Our results suggest that the serum levels of androgens in premenopausal women may be influenced by variants of the AR gene and the ER beta gene, respectively.
引用
收藏
页码:2562 / 2568
页数:7
相关论文
共 68 条
[1]   Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus [J].
Andersson, B ;
Mattsson, LA ;
Hahn, L ;
Marin, P ;
Lapidus, L ;
Holm, G ;
Bengtsson, BA ;
Bjorntorp, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :638-643
[3]   THE EFFECTS OF PROLONGED HYPERTESTOSTERONEMIA ON ADRENOCORTICAL BIOSYNTHESIS IN OOPHORECTOMIZED WOMEN [J].
AZZIZ, R ;
GAY, FL ;
POTTER, SR ;
BRADLEY, E ;
BOOTS, LR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (05) :1025-1030
[4]   Role of the ovary in the adrenal androgen excess of hyperandrogenic women [J].
Azziz, R ;
Rittmaster, RS ;
Fox, LM ;
Bradley, EL ;
Potter, HD ;
Boots, LR .
FERTILITY AND STERILITY, 1998, 69 (05) :851-859
[5]   Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor α gene and their relationship to bone mass variation in postmenopausal Italian women [J].
Becherini, L ;
Gennari, L ;
Masi, L ;
Mansani, R ;
Massart, F ;
Morelli, A ;
Falchetti, A ;
Gonnelli, S ;
Fiorelli, G ;
Tanini, A ;
Brandi, ML .
HUMAN MOLECULAR GENETICS, 2000, 9 (13) :2043-2050
[6]   The android woman - A risky condition [J].
Bjorntorp, P .
JOURNAL OF INTERNAL MEDICINE, 1996, 239 (02) :105-110
[7]   EFFECTS OF FLUTAMIDE AND AMINOGLUTETHIMIDE ON PLASMA 5-ALPHA-REDUCED STEROID GLUCURONIDE CONCENTRATIONS IN CASTRATED PATIENTS WITH CANCER OF THE PROSTATE [J].
BROCHU, M ;
BELANGER, A ;
DUPONT, A ;
CUSAN, L ;
LABRIE, F .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 28 (06) :619-622
[8]   Modulation of non-templated nucleotide addition by taq DNA polymerase: Primer modifications that facilitate genotyping [J].
Brownstein, MJ ;
Carpten, JD ;
Smith, JR .
BIOTECHNIQUES, 1996, 20 (06) :1004-+
[9]   Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate [J].
Brufsky, A ;
FontaineRothe, P ;
Berlane, K ;
Rieker, P ;
Jiroutek, M ;
Kaplan, I ;
Kaufman, D ;
Kantoff, P .
UROLOGY, 1997, 49 (06) :913-920
[10]   ORAL-CONTRACEPTIVE PILLS, GONADOTROPIN-RELEASING-HORMONE AGONISTS, OR USE IN COMBINATION FOR TREATMENT OF HIRSUTISM - A CLINICAL RESEARCH-CENTER STUDY [J].
CARR, BR ;
BRESLAU, NA ;
GIVENS, C ;
BYRD, W ;
BARNETTHAMM, C ;
MARSHBURN, PB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) :1169-1178